2023. Clinician- and Patient-Reported Outcomes with Tirbanibulin 1% Treatment for Actinic Keratosis in Routine Clinical Practice Across the U.S. (PROAK Study). SKIN The Journal of Cutaneous Medicine. 7, 3 (May 2023), 771–787. DOI:https://doi.org/10.25251/skin.7.3.3.